Product Information
PREGABALIN ER 330 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $2.8464 per EA under NDC 72205007930. Its NADAC has been published 115 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
330 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205007930
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA213226On Market Since
4/13/2021
Price Statistics
The NADAC for PREGABALIN ER 330 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 11.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8464 per EA |
|---|---|
| All-time high | $3.9513 (Sep 11, 2024) |
| All-time low | $2.4499 (Mar 19, 2025) |
| 52-week high | $3.7250 |
| 52-week low | $2.8464 |
| Median price | $3.4169 |
| Average price | $3.3517 |
| Largest weekly change | -11.7% (Jun 17, 2026) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PREGABALIN market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PREGABALIN ER 330 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN ER 330 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $2.8464 per EA (NDC 72205007930), effective Jun 24, 2026.
How has the price of PREGABALIN ER 330 MG TABLET changed over time?
Over the history we have for it, the NADAC for PREGABALIN ER 330 MG TABLET has declined 11.4%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for PREGABALIN ER 330 MG TABLET?
Since Apr 17, 2024, the NADAC for PREGABALIN ER 330 MG TABLET has ranged from a low of $2.4499 (Mar 19, 2025) to a high of $3.9513 (Sep 11, 2024), with a median of $3.4169 per EA.
Are there cheaper alternatives to PREGABALIN ER 330 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PREGABALIN ER 330 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PREGABALIN ER 330 MG TABLET?
PREGABALIN ER 330 MG TABLET (NDC 72205007930) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification